Artificial Intelligence to Accelerate Clinical Development

***Registration for this event is now closed, if you wish to enquire about attending please email laura@onenucleus.com***

In collaboration with 

With attrition rates high in drug development, increasing the costs and timescales it takes to get vital new drugs to patients, our panel will discuss examples of how artificial intelligence can help to accelerate this process, from screening meaningful biomarkers to more patient centric clinical trials.

Programme
15:00 Registration and Networking
15:30 Welcome
15:40 Panel Discussion on ‘Artificial Intelligence to Accelerate Clinical Development’
Chair: Julia Gwilt, Appleyard Lees
Panelists:
Joanne Hackett, IQVIA
Mark Hinton, Lucida Medical

16:40 Closing Remarks
16:45 Networking and Drinks
18:00 Close

Free to attend and open to all